Paid Clinical Trials in Michigan

Michigan has 2,338 paid clinical trials enrolling now across cities including Ann Arbor, Detroit and Grand Rapids. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Michigan include University of Michigan Health and Henry Ford Health, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 19, 2026.

Filter results

Filter results

State

City

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

2,338 clinical trials

↓ Download CSV

DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy

for Fuchs Endothelial Corneal Dystrophy

2 locations incl. Indianapolis

Sponsor: Design Therapeutics, Inc.

Sex: All·Age: 30+

Code: NCT07024693·Phase 2·Recruiting

Apply to this trial

Study of BHV-1400 in IgA Nephropathy

for IgA Nephropathy

14 locations incl. Farmington

Sponsor: Biohaven Therapeutics Ltd.

Sex: All·Age: 18 - 65

Code: NCT07054684·Phase 1·Recruiting

Apply to this trial

Magnesium and Cramping

for Uterine Cramps

1 location in Royal Oak

Sponsor: Corewell Health East

Sex: Female·Age: 18+

Code: NCT06745388·Phase 4·Recruiting

Apply to this trial

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

for Melanoma

6 locations incl. Grand Rapids

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07115043·Phase 1, Phase 2·Recruiting

Apply to this trial

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

for Breast Atypical Hyperplasia

3 locations incl. Kansas City

Sponsor: National Cancer Institute (NCI)

Sex: Female·Age: 45 - 74·Accepts healthy volunteers

Code: NCT06195306·Phase 2·Recruiting

Apply to this trial

Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B

for Hemophilia B

2 locations incl. Gainesville

Sponsor: CSL Behring

Sex: Male·Age: 138 Months - 206 Months

Code: NCT07080905·Phase 3·Recruiting

Apply to this trial

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

for AML (Acute Myelogenous Leukemia)

13 locations incl. Birmingham

Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All·Age: 18 - 66

Code: NCT06859424·Phase 2·Recruiting

Apply to this trial

A Study of Intravenous L-Citrulline in Patients Aged 6-21 Years Old With Sickle Cell Disease Presenting to Emergency Departments in Acute Vaso-Occlusive Crisis

for Sickle Cell Disease

6 locations incl. Washington D.C.

Sponsor: Asklepion Pharmaceuticals, LLC

Sex: All·Age: 6 - 21

Code: NCT06989567·Phase 3·Not Yet Recruiting

ELEVATE High-Risk PCI Pivotal Study

for High-Risk Percutaneous Coronary Intervention (High-risk PCI)

29 locations incl. Scottsdale

Sponsor: Magenta Medical Ltd.

Sex: All·Age: 18 - 88

Code: NCT07001332·Recruiting

Apply to this trial

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

for Solid Tumor

11 locations incl. Santa Monica

Sponsor: Astellas Pharma Inc

Sex: All·Age: 18+

Code: NCT07094204·Phase 1·Recruiting

Apply to this trial

Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)

for Androgenetic Alopecia (AGA)

71 locations incl. Birmingham

Sponsor: Veradermics, Inc.

Sex: Female·Age: 18 - 65

Code: NCT07146022·Phase 3·Recruiting

Apply to this trial

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

for Breast Cancer

22 locations incl. Duarte

Sponsor: Celcuity Inc

Sex: All·Age: 18+

Code: NCT06757634·Phase 3·Recruiting

Apply to this trial

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

for Relapsing Multiple Sclerosis

Drug: Remibrutinib

38 locations incl. Scottsdale

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 40 - 70

Code: NCT06846281·Phase 3·Recruiting

Apply to this trial

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

for Percutaneous Coronary Intervention

Drug: Inclisiran

103 locations incl. Alexander City

Sponsor: Duke University

Sex: All·Age: 18+

Code: NCT06909565·Phase 4·Recruiting

Apply to this trial

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

for Pulmonary Hypertension

25 locations incl. Birmingham

Sponsor: Tempus AI

Sex: All·Age: 18+

Code: NCT06911632·Recruiting

Apply to this trial

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

for Multiple Myeloma

10 locations incl. Los Angeles

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT06953960·Phase 1, Phase 2·Recruiting

Apply to this trial

Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Cisplatin-eligible Upper Tract Urothelial Cancer

for Urothelial Carcinoma

1 location in Ann Arbor

Sponsor: University of Michigan Rogel Cancer Center

Sex: All·Age: 18+

Code: NCT06356155·Phase 2·Recruiting

Apply to this trial

Remote Electrical Stimulation for Pain and Depression Treatment in Cirrhosis

for Cirrhosis

1 location in Ann Arbor

Sponsor: University of Michigan

Sex: All·Age: 18+

Code: NCT06932783·Recruiting

Apply to this trial

Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)

for HIV Pre-exposure Prophylaxis

31 locations incl. Birmingham

Sponsor: Gilead Sciences

Sex: All·Age: 16+·Accepts healthy volunteers

Code: NCT07047716·Phase 3·Recruiting

Apply to this trial

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

for Diabetes Mellitus, Type 2

Drug: Empagliflozin

216 locations incl. Anniston

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT07064473·Phase 3·Recruiting

Apply to this trial

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

for Neovascular Age-Related Macular Degeneration (nAMD)

54 locations incl. Scottsdale

Sponsor: 4D Molecular Therapeutics

Sex: All·Age: 50+

Code: NCT07064759·Phase 3·Recruiting

Apply to this trial

A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors.

for Advanced Solid Tumors

8 locations incl. Palo Alto

Sponsor: FoRx Therapeutics AG

Sex: All·Age: 18+

Code: NCT07356453·Phase 1·Recruiting

Apply to this trial

A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer

for Ovarian Cancer

14 locations incl. Augusta

Sponsor: Compugen Ltd

Sex: Female·Age: 18+

Code: NCT06888921·Phase 1, Phase 2·Recruiting

Apply to this trial

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

for Pancreatic Neuroendocrine Tumor (pNET)

39 locations incl. Birmingham

Sponsor: Exelixis

Sex: All·Age: 18+

Code: NCT06943755·Phase 2, Phase 3·Recruiting

Apply to this trial

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

for Alzheimer's Disease

Drug: KarXT

30 locations incl. Fullerton

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 60 - 85

Code: NCT06976203·Phase 3·Recruiting

Apply to this trial

Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

for Familial Adenomatous Polyposis (FAP)

18 locations incl. Arcadia

Sponsor: Rapamycin Holdings Inc.

Sex: All·Age: 18+

Code: NCT06950385·Phase 3·Recruiting

Apply to this trial

A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

for Metastatic Colorectal Cancer

4 locations incl. New Haven

Sponsor: BioNTech SE

Sex: All·Age: 18+

Code: NCT07079631·Phase 1, Phase 2·Recruiting

Apply to this trial

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

for Non-small Cell Lung Cancer

22 locations incl. Glendale

Sponsor: Nuvalent Inc.

Sex: All·Age: 18+

Code: NCT06765109·Phase 3·Recruiting

Apply to this trial

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

for Gastroesophageal Adenocarcinoma

7 locations incl. Newark

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07069712·Phase 2·Recruiting

Apply to this trial

Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial

for Oral Cavity Squamous Cell Carcinoma

1 location in Ann Arbor

Sponsor: University of Michigan Rogel Cancer Center

Sex: All·Age: 18+

Code: NCT07121595·Phase 2·Recruiting

Apply to this trial

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

for Advanced Solid Tumor

8 locations incl. San Diego

Sponsor: MOMA Therapeutics

Sex: All·Age: 18+

Code: NCT06974110·Phase 1·Recruiting

Apply to this trial

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)

for Alzheimer Disease

Drug: KarXT

39 locations incl. Chandler

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 55 - 90

Code: NCT07011745·Phase 3·Recruiting

Apply to this trial

Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes

for Renal Impairment After Cardiac Surgery

4 locations incl. Weston

Sponsor: 3ive Labs

Sex: All·Age: 22 - 85

Code: NCT07017933·Recruiting

Apply to this trial

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

for COPD

18 locations incl. Birmingham

Sponsor: Apreo Health, Inc.

Sex: All·Age: 40 - 84

Code: NCT06891755·Recruiting

Apply to this trial

A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

for Kidney Disease

40 locations incl. Birmingham

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT06963827·Phase 3·Recruiting

Apply to this trial

Comparing Single-Session Therapies for Chronic Pain

for Chronic Musculoskeletal Pain

2 locations incl. Chicago

Sponsor: Mark A. Lumley

Sex: All·Age: 18+

Code: NCT07008105·Recruiting

Apply to this trial

A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

for Atopic Dermatitis (AD)

48 locations incl. Phoenix

Sponsor: Bluefin Biomedicine, Inc.

Sex: All·Age: 18 - 75

Code: NCT07105488·Phase 2·Recruiting

Apply to this trial

University of Michigan COPD Identification Through Lung Cancer Screening Cohort Study - MAP2

for COPD (Chronic Obstructive Pulmonary Disease)

1 location in Ann Arbor

Sponsor: University of Michigan

Sex: All·Age: 50 - 80

Code: NCT07482475·Recruiting

Apply to this trial

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

for HER2-negative Breast Cancer Patients With Brain Metastases

17 locations incl. Duarte

Sponsor: Biostar Pharma, Inc.

Sex: All·Age: 18+

Code: NCT06764940·Phase 2·Recruiting

Apply to this trial

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

for Acute Decompensated Heart Failure

37 locations incl. Irvine

Sponsor: Reprieve Cardiovascular, Inc

Sex: All·Age: 22+

Code: NCT06898515·Phase 3·Recruiting

Apply to this trial